A practical reference on dual agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-05-28. Anything still debated is marked as such rather than presented as settled.
在生理层面，GIP 与 GLP-1 均为肠道内分泌细胞分泌的肠促胰素，进食后参与胰岛素分泌调节与胃排空抑制。Tirzepatide 通过同时激活这两条信号通路，使胰岛素分泌的葡萄糖依赖性增强，并延缓冲胃排空、降低食欲信号。与单一 GLP-1 激动相比，双靶点作用在血糖控制和体重变化上的效应幅度更大，但具体贡献比例仍在研究之中。
脂肪酸侧链的存在使该肽与血浆白蛋白结合能力增强，从而延长循环半衰期，支持每周一次给药的用药间隔。白蛋白结合同时改变组织分布特征，减慢肾脏清除速度。该设计思路在多种长效肽类药物中被反复采用，属于既定的药代动力学策略。
Tirzepatide is a synthetic linear peptide of 39 amino acids that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its sequence derives from native GIP but incorporates non-natural residues and a C20 fatty diacid moiety linked to a lysine side chain. The lipophilic chain promotes albumin binding, which slows renal clearance and extends circulation time. The unmodified peptide has a molecular formula of C225H348N48O68 and a molecular mass near 4,813 daltons.
Receptor activation by tirzepatide raises intracellular cyclic AMP through Gs-coupled signalling at both targets. At the GLP-1 receptor the downstream effect includes glucose-dependent insulin release, suppressed glucagon secretion, delayed gastric emptying, and reduced appetite signalling in the hypothalamus. GIP receptor engagement adds insulinotropic activity and appears to influence lipid handling in adipose tissue. Because both receptors are stimulated at the same time, the pharmacological profile differs from that of selective GLP-1 receptor agonists, and the relative contribution of each arm remains an area of active investigation.
Clinical development proceeded through large phase 3 programmes in type 2 diabetes and in obesity or overweight with at least one weight-related comorbidity. Regulatory approvals followed in several jurisdictions for both indications. Weekly subcutaneous dosing reflects an elimination half-life of roughly five days. Open questions include the durability of metabolic effects after treatment stops, long-term cardiovascular and hepatic outcomes beyond completed trials, and whether the dual mechanism confers benefits independent of total receptor occupancy. Published literature continues to expand on these points. Substantial uncertainty remains about interindividual variability in response.
| Property | Value | Notes |
|---|---|---|
| 分子类型 | 合成修饰肽 | 39 个氨基酸，含脂肪酸侧链 |
| 受体靶点 | GIP 与 GLP-1 受体 | 双重激动剂 |
| 分子量 | 约 4.8 kDa | 以游离肽计 |
| 外观 | 白色至类白色粉末 | 冻干形态常见 |
| 溶解性 | 可溶于水及水性缓冲液 | 溶解后宜低温保存 |
Tirzepatide is a synthetic peptide that acts as a dual agonist at the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The molecule contains 39 amino acids and features a C20 fatty diacid moiety attached via a linker, which promotes albumin binding and extends its circulating half-life. Its sequence incorporates non-natural amino acids and modifications that reduce susceptibility to degradation by dipeptidyl peptidase-4. This dual receptor activity distinguishes it from selective GLP-1 receptor agonists.
The GIP receptor is expressed in pancreatic islets, adipose tissue, and the central nervous system, while GLP-1 receptors are found in pancreatic islets, the gastrointestinal tract, and the brain. Activation of both receptors can enhance glucose-dependent insulin secretion and reduce glucagon release. The relative contribution of each receptor to the overall pharmacological effect remains an area of ongoing investigation. Preclinical studies suggest that GIP receptor agonism may modulate appetite and energy balance, but the precise mechanisms in humans are not fully established.
In clinical research, tirzepatide has been studied in randomized controlled trials for glycemic control and body weight reduction. These trials typically measure changes in hemoglobin A1c and body weight over periods of several months. The drug is administered by subcutaneous injection, and its pharmacokinetic profile supports once-weekly dosing. Post-marketing surveillance continues to evaluate long-term outcomes and rare adverse events.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Myomeres are blocks of skeletal muscle tissue arranged in sequence, commonly found in aquatic chordates. Myomeres are separated from adjacent myomeres by fascia consisting of connective tissue, known as myosepta. Myomere counts are sometimes used for identifying specimens using meristics, since their number corresponds to the number of vertebrae in the adults. Myomere location varies, with some species containing these only near the tails, while some have them located near the scapular or pelvic girdles. Depending on the species, myomeres could be arranged in an epaxial or hypaxial manner; hypaxial refers to ventral muscles (those of the "stomach" region) and related structures, while epaxial refers to more dorsal muscles (those of the "back"). The horizontal septum divides these two regions in vertebrates from cyclostomes (jawless lamprey and hagfish) to gnathostomes (jawed fish). In terrestrial chordates, which are gnathostomes themselves, the myomeres become fused as well as indistinct, due to the disappearance of myosepta.
== Plant interactions == Post-harvest decays are a main source of fruit loss, with the most common source of Citrus fruit decay being infections caused by P. digitatum and P. italicum. Penicillium digitatum is responsible for 90% of citrus fruits lost to infection after harvesting, and is considered the largest cause of post-harvest diseases occurring in California citrus fruits. Its widespread impact derives from the post-harvest disease it causes in citrus fruits known as green rot or mould. As a wound pathogen, the disease cycle begins when P. digitatum conidia germinate with release of water and nutrients from the site of injury on the fruit surface. For example, after infection at 24 °C, rapid growth ensues, with active infection taking place within 48 hours, and initial symptom onset occurring within 3 days. As temperature at time of infection decreases, the delay of initial symptom onset increases. Initial symptoms include a moist depression on the surface, which expands as white mycelium colonizes much of the surface. The centre of the mycelial mass eventually turns olive as conidial production begins. Near the end of the disease cycle, the fruit eventually decreases in size, and develops into an empty, dry shell. This end result is commonly used to distinguish P. digitatum infections from those of P. italicum, which produce a blue-green mould and ultimately render the fruit slimy. Infection with green mould at 25 °C (77 °F) can last 3 to 5 days, with the rate of conidial production per infected fruit being as high as 1–2 billion conidia.
Tyne and Wear is divided into 12 parliamentary constituencies. Historically, the area has been a Labour stronghold; South Shields is the only Parliamentary constituency that has never returned a Conservative Member of Parliament (MP) to the House of Commons since the Reform Act of 1832.
Sources: en.wikipedia.org
== Types == Many rheumatic disorders of chronic, intermittent pain (including joint pain, neck pain or back pain) have historically been caused by infectious diseases. Their etiology was unknown until the 20th century and not treatable. Postinfectious arthritis, also known as reactive arthritis, and rheumatic fever are other examples. In the United States, major rheumatic disorders are divided into 10 major categories based on the nomenclature and classification proposed by the American College of Rheumatology (ACR) in 1983.
Agüero insisted that she "never harmed any person, much less a baby." On 30 April, the prosecution formally requested the sentence of life imprisonment for Agüero, accusing her of deliberately injecting the babies with potassium and insulin to gain the attention of the medical staff when she attempted to resuscitate them. On 8 May, Agüero's defense lawyer gave the final statement before the court, saying that Agüero is innocent and that she was framed by "the power" (in reference to the provincial government) to blame her for the negligence of providing expired medications and concealing systematic malpractice among the hospital's medical personnel. Agüero's defense counsel later concluded his statement formally requesting the jury to acquit Agüero of all charges. In their final impact statement before the court, the mothers of the murdered babies accused Agüero and her lawyers of falsely implying that they "cried for money" (in relation to civil trials against the provincial government) and also demanded that Agüero be sentenced to life in prison. Agüero gave her final statement on 12 June, with the verdict expected for 18 June. Agüero denied the charges again, and in a tense moment in court, accused the mothers of the babies of being "scripted", prompting emotional reactions from the gallery. Agüero, in part, said:
Conservatives offered Thorpe the Home Office if he would join a coalition government with Heath. Thorpe was personally in favour of it, but the party insisted it would only agree pending a clear government commitment to introducing proportional representation (PR) and a change of prime minister. The former was unacceptable to Heath's cabinet and the latter to Heath personally, so the talks collapsed. Instead, a minority Labour government was formed under Harold Wilson but with no formal support from Thorpe. In the October 1974 general election, the Liberals total vote slipped back slightly (and declined in each of the next three) and the Labour government won a wafer-thin majority. Thorpe was subsequently forced to resign after allegations that he attempted to have his homosexual lover murdered by a hitman. The party's new leader, David Steel, negotiated the Lib–Lab pact with Wilson's successor as prime minister, James Callaghan. According to this pact, the Liberals would support the government in crucial votes in exchange for some influence over policy. The agreement lasted from 1977 to 1978, but proved mostly fruitless, for two reasons: the Liberals' key demand of PR was rejected by most Labour MPs, whilst the contacts between Liberal spokespersons and Labour ministers often proved detrimental, such as between Treasury spokesperson John Pardoe and Chancellor of the Exchequer Denis Healey, who were mutually antagonistic.
Sources: en.wikipedia.org
它属于合成修饰肽，同时激动 GIP 与 GLP-1 两种肠促胰素受体。这类分子通常被称为双重肠促胰素受体激动剂，与选择性 GLP-1 激动剂在靶点范围上不同。
分子上的脂肪酸侧链使其与血浆白蛋白结合增强，显著延长循环半衰期。半衰期延长后，稳定血药浓度可在较长的给药间隔内维持，因此常见用法为每周一次。
同时激活两条肠促胰素通路可能在胰岛素分泌、胃排空和食欲调节上产生叠加效应。与单靶点相比，临床研究中观察到的血糖与体重变化幅度通常更明显，但各通路的具体贡献比例尚无定论。
It is a dual GIP and GLP-1 receptor agonist, frequently grouped with incretin-based peptide therapeutics. It is a peptide rather than a small molecule and is given by subcutaneous injection.